Home › Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization
 

Keywords :   


Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization

2016-01-15 11:31:11| Industrial Newsroom - All News for Today

RIYADH, Saudi Arabia - Varian Medical Systems (NYSE: VAR) has announced today its ProBeam proton therapy system is the first such system to receive Saudi FDA medical devices marketing authorization. "We are pleased to have the opportunity to make life-saving proton therapy treatments available to cancer patients...

Tags: system receive therapy saudi

Category:Industrial Goods and Services

Latest from this category

All news
31.10Consolidated Financial Statements for the six-month period ended September 30, 2024
31.10Notice regarding the revision of the business results forecasts
Industrial Goods and Services »
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »